FEDERAL COURT OF AUSTRALIA
Equity Financial Planners Pty Ltd v AMP Financial Planning Pty Ltd [2024] FCA 1036
File number(s): VID 498 of 2020 Judgment of: MCELWAINE J Date of judgment: 6 September 2024 Catchwords: REPRESENTATIVE PROCEEDINGS– application for approval of a settlement pursuant to s 33V(1) of the Federal Court of Australia Act 1976 (FCA Act)- where 20% of group members object- the importance of objections and the protective function of the Court explained- whether proposed settlement is fair and reasonable-consideration of proposed deductions from settlement sum- ATE insurance premiums and internal expenses disallowed- whether suppression and non-publication orders are necessary to prevent prejudice to the administration of justice-duration of orders- whether orders until further order comply with the requirement to fix a definite period at s 37AJ of the FCA Act-limited confidentiality orders made with variable duration periods- settlement with adjustments approved Legislation: Corporations Act 2001 (Cth)
Federal Court of Australia act 1976 (Cth) ss 33J(1), 33V, 33X, 33Y(2), 33ZB, 37AF, 37AG(1)(a)
Legal Profession Uniform Law, s 172
The Class Actions Practice Note (GPN-CA)
Cases cited: Asirifi-Otchere v Swan Insurance (Aust) Pty Ltd (2020) 385 ALR 625
Blairgowrie Trading Ltd v AllcoFinance Group Ltd (Receivers and Managers Appointed) (in liq) (No 3) (2017) 343ALR 476
BMW Australia Ltd v Brewster (2019) 269 CLR 574
Bolitho v Banksia Securities Ltd (No 6) [2019] VSC 653
Botsman v Bolitho (No 1) [2018] VSCA 278
Bradshaw v BSA Ltd (No 2) [2022] FCA 1440
Camilleri v The Trust Company (Nominees) Ltd [2015] FCA 1468
Dyczynski v Gibson (2020) 280 FCR 583
Equity Financial Planners Pty Ltd v AMP Financial Planning Pty Ltd [2023] FCA 741
Equity Financial Planners Pty Ltd v AMP Financial Planning Pty Ltd (No 2) [2023] FCA 1033
Ewok Pty Ltd (Trustee) v Wellard Ltd [2024] FCA 296
Fordham v Commonwealth Bank of Australia Ltd [2023] FCA 1106
Fowkes v BostonScientific Corporation [2023] FCA 230
Galactic Seven Eleven Litigation Holdings LLC v Davaria (2024) 302 FCR 493
Ghee v BT Funds ManagementLtd [2023] FCA 1553
Inabu PtyLtd v Leighton Holdings Ltd [2014] FCA 622
Jenkins v Northern Territory of Australia (No 4) [2021] FCA 839
Kelly v Willmott Forests (in liq) (No 4) (2016) 335 ALR 439
Lee v Deputy Commissioner of Taxation (2023) 296 FCR 272
Luke v Aveo Group Ltd (No 3) [2023] FCA 1665
Motorola Solutions Inc v Hytera Communications CorporationLtd (No 2) [2018] FCA 17
Timbercorp Finance Pty Ltd (in liq)v Collins (2016) 259 CLR 212
Webb v GetSwift Ltd (No 7) (2023) 414 ALR 500
Wellesley v Duke of Beaufort (1827) 2 Russ 1
Division: General Division Registry: Victoria National Practice Area: Commercial and Corporations Sub-area: Commercial Contracts, Banking, Finance and Insurance Number of paragraphs: 194 Date of last submission/s: 4 September 2024 Date of hearing: 29-30 August 2024 Counsel for the Applicant Mr R Craig KC with Mr R Rozenberg and Ms J Nikolic Solicitor for the Applicant
Keep reading for free
Create a free CaseChat account to read Equity Financial Planners Pty Ltd v AMP Financial Planning P... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2024] FCA 1036
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
1. Pursuant to s 33V of the Federal Court of Australia Act 1976 (Cth) (Act), the settlement of this proceeding (Settlement) be approved on the terms set out in:
(a) the Settlement Deed, being pages 4 to 36 to Confidential Exhibit CJP–1 of the Affidavit of Christopher John Pagent sworn 18 April 2024; and
(b) the Settlement Distribution Scheme, being pages 1 to 32 of Confidential Exhibit CJP–8 of the Affidavit of Christopher John Pagent sworn 26 June 2024 (Settlement Distribution Scheme).
2. Pursuant to s 33V of the Act, the Court authorises the Applicant nunc pro tunc on behalf of the Group Members (as defined in the Settlement Deed) (Group Members) to enter into and give effect to the Settlement Deed and the transactions contemplated thereby for and on behalf of the Group Members.
3. Pursuant to s 33ZB of the Act, the persons affected and bound by the Settlement are the Applicant, the Respondent, the Group Members and Augusta Pool 523 Limited (Funder).
Appointment of Administrator, Independent Barrister and Independent Senior Counsel
4. Pursuant to ss 33V and 33ZF of the Act, the Court appoints Mr Andrew Ross and Mr Ben Mahler of KordaMentha as the administrator of the Settlement Distribution Scheme (Administrator) to act in accordance with the Settlement Distribution Scheme and be given the powers and immunities contemplated by the Settlement Distribution Scheme.
5. The Administrator has liberty to apply in relation to any matter arising in relation to the Settlement Distribution Scheme.
6. Pursuant to ss 33V and 33ZF of the Act, the Court appoints Mr Peter Strickland and Ms Jane Buncle, each of counsel, as the Independent Barrister as defined in the Settlement Distribution Scheme, to perform the functions set out in the Settlement Distribution Scheme.
7. Pursuant to ss 33V and 33ZF of the Act, the Court appoints Mr Bernard Quinn KC as the Independent Senior Counsel as defined in the Settlement Distribution Scheme, to perform the functions set out in the Settlement Distribution Scheme.
Applicant and Sample Claimant Reimbursements
8. Pursuant to s 33V of the Act, the following payments be approved as, respectively, the Applicant’s Reimbursement and the Sample Claimant’s Reimbursement, as defined in the Settlement Distribution Scheme:
a. Applicant’s Reimbursement:
i. Ms Kylie Braschey ($30,000)
ii. Ms Leanne Scott ($30,000)
b. Sample Claimant’s Reimbursement – Mr Michael Finch ($20,000).
Approval of amounts to be deducted under the Settlement Distribution Scheme
9. Pursuant to section 33V(2) of the Act, the deductions from the Resolution Sum as outlined in the Settlement Distribution Scheme (updated as necessary to reflect the below deductions and figures) be approved, namely:
a. the “Funder Commission” totalling $26,578,805.83, to be paid to the Funder;
b. the “Applicant’s Paid Legal Costs” in the total amount of $10,573,022.33 (GST inclusive), to be paid to the Funder;
c. the “Applicant’s Unpaid Legal Costs” in the amount of $509,989.98 (GST inclusive), to be paid to the Applicant’s solicitors;
d. the “Applicant’s Future Legal Costs” in the amount of $1,009,926.02 (GST inclusive), to be paid to the Applicant’s solicitors;
e. a further amount in respect of the “Applicant’s Future Legal Costs” up to the amount of $195,800 (GST inclusive), subject to any further order varying that amount, to be paid to the Applicant’s solicitors;
f. the “Security Costs” in the amount of $360,259.96, to be paid to the Funder;
g. the “Applicant’s Reimbursement” as described in Order 8(a) above, to be paid to Ms Braschey and Ms Scott;
h. the “Sample Claimant’s Reimbursement” as described in Order 8(b) above, to be paid to Mr Finch;
i. the “Adverse Costs Order Reimbursement” in the amount of $58,500, to be paid to the Funder;
j. the “Contradictor’s Costs”, in the amount of up to $100,000.00, to be paid to the Contradictor and his junior, subject to any further order of the Court varying this amount;
k. the “Costs Referee’s Costs”, in the amount of $55,000 (GST inclusive), to be paid to the Costs Referee;
l. the “Administrator’s Costs” in the amount of $1,006,000.00, subject to any further order of the Court varying this amount;
Dismissal
10. Pursuant to ss 22, 23 or 33ZF of the Act or r 1.32 of the Federal Court Rules 2001 (Cth) (FCR) and/or the Court’s implied jurisdiction, and with effect from the date on which the final distribution of the Resolution Sum occurs under the Settlement Distribution Scheme, the proceeding against the Respondent be dismissed:
a. in accordance with the Settlement Deed, without prejudice to:
i. the right of any party to the Settlement Deed to make an application to enforce the Settlement Deed in a new proceeding;
ii. the right of any Group Member to make an application to the Court in accordance with the terms of the Settlement Distribution Scheme; and
iii. the right of the Administrator to refer any issues relating to the Settlement Distribution Scheme to the Court for direction or determination in accordance with the terms of the Settlement Distribution Scheme; and
b. on the basis that there be no order as to costs as between the Applicant and the Respondent and all previous costs orders in the proceeding between them are vacated.
Security for costs
11. All orders requiring the Applicant to provide security for costs are vacated and the security provided by the Funder, pursuant to orders made on 15 December 2020 and 1 June 2022, be paid to the Administrator.
Funding equalisation
12. Pursuant to s 33V and/or s 33ZF of the Act, the Funder Commission payable to the Funder by the Applicant and those Group Members who have entered into a litigation funding agreement with the Funder be apportioned on a pro rata basis between all Group Members and deducted from the Resolution Sum payable to all Group Members.
Confidentiality and undertakings
13. Pursuant to ss 37AF and 37AG(1)(a) of the Act, to prevent prejudice to the proper administration of justice, the publication of each of the items listed in Annexure A to these orders (the Confidentiality Claims Schedule) be limited to the persons and, or alternatively, subject to the limitation identified.
14. The applicant is to file by 4 pm on 10 September 2024 two consolidated PDF versions of the documents in the Confidentiality Claims Schedule, with the authorised redactions where applicable, one version containing the documents prior to the expiry of the appeal period and the other thereafter.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Annexure A – Confidentiality Claims Schedule
Item
Document
Date
Section over which confidentiality is claimed
Accessible by
Duration
Category 1 Information: Information which the parties have agreed to keep confidential (only applies to the Settlement Deed as per ruling of McElwaine J).
1.
Affidavit of Christopher John Pagent
18 April 2024
The whole of the Settlement Deed and the whole of the executed copies of the Settlement Deed, executed by the Applicant AMPFP, Corrs and Augusta, contained in Confidential Exhibit CJP–1 at pages 4–164.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) Group Members (upon undertaking to maintain confidentiality); (e) the Contradictor; (f) the Funder; (g) the Funder’s legal representatives; (h) the Respondent; and (i) the Respondent’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until approval of the settlement
Category 2 Information: Information which discloses the proposed distribution the Settlement Sum, or which is otherwise privileged, disclosed to the Court on a confidential basis for the purposes of the settlement approval hearing.
2.
Interlocutory Application
18 April 2024
The following paragraphs of Annexure A, being the Unredacted Settlement Notice: [62], [66]–[67], [69]–[73], [76], [77] (but only the words between “the Independent Barrister” and “to an independent senior counsel”); Annexure A to the Settlement Notice.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) Group Members (upon undertaking to maintain confidentiality); (e) the Contradictor; (f) the Funder; and (g) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until the expiry of the appeal period
3.
Affidavit of Christopher John Pagent
18 April 2024
Paragraphs [117], [121]–[122], [124]–[128], [131], [132] (but only the words between ‘the Independent Barrister’ and ‘to an independent senior counsel’).
The following parts of the Settlement Distribution Scheme contained at pages 165–195 of Confidential Exhibit CJP–1:
· the information contained between the definitions of “Group Member” and “Opt-Out Deadline” on page 172; and
· the following parts of Schedule 3 contained at pages 187–195:
· the words between “determination of the” and “to their claim” in definition of Statutory Declaration;
· cll 2.3, 2.4, 4, 5, 7;
· cl 8(c)(iv) (but only the words following ‘the Independent Barrister’s determination of the’); and
· cl 8(e) (but only the words between “the Independent Barrister in respect of” and “(Appeal Threshold)”.
4.
Affidavit of Christopher John Pagent
23 April 2024
The following paragraphs of Exhibit CJP–3, being the Unredacted Settlement Notice: [62], [66]–[67], [69]–[73], [76], [77] (but only the words between “the Independent Barrister’ and ‘to an independent senior counsel’); Annexure A to the Settlement Notice.
5.
Affidavit of Christopher John Pagent
26 June 2024
Paragraphs [87]–[89], [91]–[100], [104]–[107] (up to the table extract), [108] (but only the words between “the Independent Barrister of the” and “to an Independent Senior Counsel”) and [201] (but only following the words “Settlement Distribution Scheme”) to the end of [207].
The redactions indicated in Confidential Exhibit CJP–7 (Objections).
The following parts of the Settlement Distribution Scheme contained at pages 1–32 of Confidential Exhibit CJP–8:
· the information contained between the definitions of “Group Member” and “Opt-Out Deadline” on page 8;
· the following parts of Schedule 3 contained at pages 24–32:
· the words between “determination of the” and “to their claim” in definition of Statutory Declaration on page 26;
· cll 2.3, 2.4, 4, 5, 7;
· cl 8(c)(iv) (but only the words following “the Independent Barrister’s determination of the”); and
· cl 8(e) (but only the words between “the Independent Barrister in respect of” and “(Appeal Threshold)”.
5A.
Affidavit of Christopher John Pagent
26 June 2024
Paragraphs [68] (but only the information contained after the words “replicated below”), [75] (but only the information contained after the words “as follows”), [107] (but only the information contained after the words “as follows”). These paragraphs extract information from pages 165–175 of CJP-8.
The whole of Confidential Exhibit CJP–5 (Confidential Opinion).
The following parts of Confidential Exhibit CJP-6 (Costs Referee’s Reports):
· the third and fourth sentence of paragraph [64] on page 23; and
· the remainder of the second sentence following the words “For example,” in [65] on page 23.
Pages 165–175 and 366 of Confidential Exhibit CJP-8.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
10 years or until further order
Category 3 Information: Information which discloses: (i) sensitive aspects of the funding arrangements provided by the Funder; or (ii) privileged material provided to the Funder
6.
Affidavit of Christopher John Pagent
18 April 2024
The following parts of the Early Stage Funding Agreement contained in Confidential Exhibit CJP–1: key term (5), (6) and (7) on page 196.
The following parts of the Litigation Funding Agreement between the Applicant and the Funder contained in Confidential Exhibit CJP–1:
· the first definition after ‘definitions and interpretation’ on page 212;
· the sentences following ‘Item(k) of Schedule 2’ on page 212;
· the definitions following ‘Beneficiaries’ on page 213–214;
· the definition between ‘Business Day’ and ‘Claim’ on page 214;
· the description following the definition of ‘Claim Proceeds’ on page 214;
· the conclusion of the definition of ‘Early Stage Funding Amount’ following the words ‘means the amount of’ at page 216;
· the definition between ‘Loss’ and ‘Multiplicity Order’ on page 217;
· the sub points following ‘Tranche 1’, ‘Tranche 2’ and ‘Tranche 3’ on page 220;
· the words contained at the bottom of the header of the table on page 239;
· the information contained after ‘Option 1’ and ‘Option 2’ in schedule 2(d) on page 240;
· the particulars of schedule 2(e) on page 240;
· the particulars of schedule 2(f) on page 240;
· the particulars of schedule 2(g) on page 241;
· the particulars of schedule 2(i) on page 241;
· the information after ‘A/C Name’, ‘SWIFT CODE’, ‘BSB’ and ‘A/C’ under schedule 2(j) on page 241;
· the particulars of schedule 2(k) on page 241;
· the information contained following ‘the greater of’ in schedule 2(l) on page 241;
· clause 7.2.5 between the words ‘to’ and ‘set’ on page 251;
· schedule 6(1.1)(a)-(f) on page 254 after ‘the following basis:’; and
· schedule 7(1)-(4) on page 255 after ‘approval of any Settlement:’
The following parts of the Litigation Funding Agreement between the Funder and one of the Group Members contained in Confidential Exhibit CJP–1:
· the first definition after ‘definitions and interpretation’ on page 260;
· the sentences following ‘Item(k) of Schedule 2’ on page 260;
· the definitions following ‘Beneficiaries’ on page 261–262;
· the definition between ‘Business Day’ and ‘Claim’ on page 262;
· the description following the definition of ‘Claim Proceeds’ on page 262;
· the conclusion of the definition of ‘Early Stage Funding Amount’ following the words ‘means the amount of’ at page 264;
· the sub points following ‘Tranche 1’, ‘Tranche 2’ and ‘Tranche 3’ on page 268;
· the words contained at the bottom of the header of the table on page 287;
· the information contained after ‘Option 1’ and ‘Option 2’ in schedule 2(d) on page 288;
· the particulars of schedule 2(e) on page 288;
· the particulars of schedule 2(f) on page 288;
· the particulars of schedule 2(g) on page 289;
· the particulars of schedule 2(i) on page 289;
· the information after ‘A/C Name’, ‘SWIFT CODE’, ‘BSB’ and ‘A/C’ under schedule 2(j) on page 289;
· the particulars of schedule 2(k) on page 289;
· the information contained following ‘the greater of’ in schedule 2(l) on page 289;
· clause 7.2.5 between the words ‘to’ and ‘set’ on page 299;
· schedule 6(1.1)(a)-(f) on page 302 after ‘the following basis:’; and
· schedule 7(1)-(4) on page 303 after ‘approval of any Settlement:’
The following parts of the First Instance ATE Policy contained in Confidential Exhibit CJP–1:
· schedule 1(6.) following ‘Premium:’ on page 316; and
· schedule 1(7.) following ‘Limit:’ on page 316.
The following parts of the Appeal ATE Policy contained in Confidential Exhibit CJP–1:
· item 5 of the schedule between ‘Stage 1:’ and ‘($60,000)’ on page 334;
· item 5 of the schedule between ‘Stage 2:’ and ‘($87,500)’ on page 334;
· item 5 of the schedule under ‘Deferred Premium’ between ‘(i)’ and ‘(i.e. $165,000)’ on page 334;
· item 5 of the schedule under ‘Deferred Premium’ between ‘(ii)’ and ‘(i.e. $240,000)’ on page 334;
· item 6 of the schedule on page 334 after ‘Limit:’; and
· item 7 of the schedule on page 335 after ‘Participating Insurers’.
The following parts of the Affidavit of Christopher John Pagent sworn 18 April 2024:
· The figure following the word ‘up to’ in paragraph [46];
· The figure following the word ‘amount of’ in paragraph [52];
· The words following the words ‘of the claims’ in paragraph [65];
· The figure following the words ‘limit of’ in paragraph [67];
· The figure following the words ‘limit of’ in paragraph [72]; and
· Paragraphs [94] from the words ‘circumstances’ to the end of [96].
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until the expiry of the appeal period
7.
Affidavit of Christopher John Pagent
18 April 2024
The following parts of the First Instance ATE Policy contained in Confidential Exhibit CJP–1: the remainder of page 317 following ‘Insurer Subscriptions’.
The following part of the Litica ATE Premium Invoice dated 20 May 2020 contained at page 322 of the Confidential Exhibit CJP–1: the information between ‘please make payments to:’ and ‘Thank you’.
The following part of the Litica ATE Premium Top Up Invoice dated 9 November 2023 contained at page 341 of the Confidential Exhibit CJP–1: the information following ‘please make payments to:’.
The following part of the Litica Invoice to The Judge dated 17 December 2020 contained at page 342 of the Confidential Exhibit CJP–1: the information between ‘please make payments to:’ and ‘Thank you’.
The following part of the PartnerRe Invoice to Augusta dated 18 March 2021 contained at page 345 of Confidential Exhibit CJP–1: the information following ‘Name and address of bank:’.
The following part of the Litica Invoice to The Judge dated 2021 contained at page 346 of the Confidential Exhibit CJP–1: the information between ‘please make payments to:’ and ‘Thank you’.
The following part of the Litica Invoice to Augusta dated 9 June 2022 contained at page 347 of the Confidential Exhibit CJP–1: the information between ‘please make payments to:’ and ‘Thank you’.
The following part of the Litica Invoice to Augusta dated 26 September 2022 contained at page 348 of the Confidential Exhibit CJP–1: the information between ‘please make payments to:’ and ‘Thank you’.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
10 years or until further order
8.
Affidavit of Christopher John Pagent
26 June 2024
Paragraphs [124] following the word “circumstances” to the end of [127].
Paragraph [130(i)] following the words “proposal whereby commission was” to the end of the sub-paragraph.
The following parts of Confidential Exhibit CJP-6 (Costs Assessors Reports):
· The words between “funding” and “to obtain advice” in [12] on page 12; and
· The penultimate sentence in [42] on page 17.
Pages 235–352 and 362–363 of Confidential Exhibit CJP–8.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until expiry of the appeal period
9.
Affidavit of Chris Martin
4 July 2024
The following parts of the affidavit of Chris Martin affirmed on 4 July 2024:
· paragraph [23] (but only the words following “commencement of the proceedings and”);
· paragraph [27] (but only the words following “that included the following”);
· paragraphs [29] (but only the words following “greater of either” to the end of [30]);
· paragraph [34] (but only the figure between the words “amount of approximately” and “to fund the costs”);
· paragraph [36] (but only the words following “CEO of AVL, and me; and”)
· paragraph [42] (but only the figure between “contained a limit of” and “with an upfront premium”); and
· paragraph [43] (but only the figure between “with the limit of” and “with an upfront premium”).
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until the expiry of the appeal period
10.
Exhibit CM-1
4 July 2024
The following parts of Exhibit CM–1:
· page 13 paragraph 29;
· pages 23–25 (until the words “Cristopher Symons QC”;
· pages 26 (under the words “Review Panel Legal Report) to 28;
· pages 55 to 66; and
· pages 68–83.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
10 years or until further order
11.
Exhibit CM-1
4 July 2024
The following parts of Exhibit CM–1:
· pages 1–7;
· page 14 paragraph 36 to page 18 (above the names at the bottom of the page);
· page 14 paragraph 35;
· pages 19 (under the words “Review Panel Economics Report”) to 21 (but only information above the words “The Review Member has provided a positive recommendation for funding this matter”); and
· page 85–92.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until the expiry of the appeal period
12.
Exhibit CM-1
4 July 2024
The following parts of Exhibit CM–1:
· the redactions indicated on page 96;
· the redaction indicated on page 97;
· page 98 (but only the figure between the words “shall be distributed with” and “paid to the Funder” and the figure between the words “the Funder and” and “paid to the Insurer”); and
· page 106 (but only the redaction indicated on that page).
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Two years or until further order
13.
Funder’s Outline of Submissions
19 July 2024
The following paragraphs of the Funder’s Outline of Submissions:
· [14] (but only the figure between “seed funding of up to” and “for an opinion”);
· [15] (but only the words between “and contingent on” and “The relevant approvals”);
· [18] (but only the words following “in all the circumstances”);
· [22] (but only the words between “Resolution Sum” and “Augusta agreed”);
· [29] (but only the figure between the words “fee is equal to” and “of the aggregate of”, the figure between the words “Early Stage Funding Amount being” and “and the total amount” and the figure at the end of that paragraph);
· [35] (but only the figure between the words “with a limit of” and “from Partner Re Ireland DAC”);
· [36] (but only the figure between the words “with a limit of” and “The upfront premium”);
· [47] (but only the words between “being” and “the relevant Project Costs”);
· [51] (but only the words between “the alternative proposal was calculated as” and “Having regard to”, the words between “Having regard to” and “the alternative proposal”, and the words following “a commission based upon”);
· [52] (but only the figure between the words “approximately” and “The Funding Terms also referred to ATE premiums” and the figure between “total funding amount” and “There has therefore been no meaningful variation”);
· [55] (but only the figure between the words “in the vicinity of” and “The proceedings could not”);
· [56] (but only the words between “The Funding Terms noted” and “reflecting a significant period”);
· [57] (but only the words between “anticipated that the position on” and “Similarly, the funding application provided” and the figure between the words “deployed capital of approximately” and “prior to the first resolution”);
· [59] (but only following the words “the litigation was in respect of the”);
· [60] (but only following the words “heightened in the circumstances where the”);
· [61] (but only the figure between the words “to spend approximately” and “to fund the costs of the appeal”);
· [66] (but only the words between “which had a limit of” and “The ATE Appeal Policy” and the figure between “up to a limit of” and “Augusta seeks a deduction”); and
· [75] (but only the figure between the words “a sum of approximately” and “Further, Augusta expended”).
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until the expiry of the appeal period
14.
Affidavit of Cigdem Kadayifci
23 August 2024
The following parts of the document annexed to the affidavit and entitled “Frequently asked questions”: From the words “free ride” to “as set out above” on page 196.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; (d) the Contradictor; (e) the Funder; and (f) the Funder’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
Until the expiry of the appeal period
Category 4 Information: Information which may be subject to a claim for confidentiality by Ms Mary Benton.
[Not used]
Category 5 Information: Information which discloses sensitive information regarding alternative funding proposals.
[Not pressed]
Category 6 Information: Information which discloses without prejudice communications authored by AMPFP, disclosed to the Court on a confidential basis for the purposes of the settlement approval hearing.
15.
Affidavit of Christopher John Pagent
26 June 2024
Paragraphs [34(a)–(g)], [35], and [54(a)–(b)].
The following parts of Confidential Exhibit CJP–8:
· page 33; and
· pages 82–164.
*Note that pages 34–81 of Confidential Exhibit CJP–8 were not in evidence.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; and (d) the Contradictor; (e) the Funder; (f) the Funder’s legal representatives; (g) the Respondent; and (h) the Respondent’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
10 years or until further order.
Category 7 Information: Information which discloses without prejudice communications authored by the Applicant, disclosed to the Court on a confidential basis for the purposes of the settlement approval hearing.
16.
Affidavit of Christopher John Pagent
26 June 2024
Paragraphs [69] and [73] (from the word “methodology”) to the end of [74], including footnote 1.
Pages 176–234 of Confidential Exhibit CJP–8.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; and (d) the Contradictor; (e) the Funder; (f) the Funder’s legal representatives; (g) the Respondent; and (h) the Respondent’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
10 years or until further order.
Category 8 Information: Personal information of group members (including addresses, email addresses etc).
17.
Affidavit of Christopher John Pagent
26 June 2024
Pages 368–376, 387 and 389–396 of Confidential Exhibit CJP–8.
The following persons: (a) the Court; (b) the Applicant; (c) the Applicant’s legal representatives; and (d) the Contradictor; (e) the Funder; (f) the Funder’s legal representatives; (g) the Respondent; and (h) the Respondent’s legal representatives.
These permitted disclosures are on the terms that none of these persons or entities disclose such material or any part of it to any person or entity other than those listed above.
10 years or until further order
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
The interlocutory application for settlement approval gave notice that Equity Financial intends to apply for a funding equalisation order to apportion the cost of the Funder’s entitlements pursuant to the litigation funding agreements equally as between the Group Members, regardless of whether a Group Member entered into a funding agreement.CONSIDERATION In what follows, I express some of my findings and reasons at a level of generality so as not to disclose material that is subject to confidentiality orders. MATTERS RAISED IN THE OBJECTIONS In assessing a settlement, the views of objecting Group Members “provide a convenient focus for the Court” in the identification “of any features of a settlement that are obviously unreasonable or unfair: Fowkes at [38] per Lee J. In this proceeding, the objectors are all people, some with long-standing commercial and professional relationships with AMPFP, either individually or through corporate structures. In summary, 92 notices of objection have been provided from 86 Group Members. A convenient summary of the objections is contained in the third affidavit made by Christopher Pagent, which I am satisfied is accurate and which I adopt: I have considered the terms of each objection. Many are deeply personal: some attach documents in support of a claim that the likely amount to be received pursuant to the Distribution Scheme is less than the objector’s “contractual entitlement”. Disappointment, grievance and personal suffering are common themes. For example, one objector in part says:This entire process has seen AMP duck and weave their way around their responsibility. This responsibility sits at a professional, ethical, and human level and I believe AMP have missed the mark in relation to the settlement.We have heard from AMP executives regarding this settlement and how it is a material step forward in restoring the relationship between the adviser network and licensee, yet this offer comes with the bitter pill that it is AMP walking away unaccountable for the irreplaceable losses, grief, distress, anger, and pain they have caused even though the Courts have already found them guilty.We all know stories where advisers, businesses, families, and other relationships have fallen or been torn apart while the corporate juggernaut, being AMP, continues to forge ahead seemingly oblivious or undeterred by these ramifications.In my opinion, the offer made continues to support this view, as it does not adequately compensate those impacted on any of these levels. In contrast, the Contradictor does not accept that deduction of the claimed ATE insurance premiums is fair and reasonable and with some force submits that I should not approve of it. In forming that view, the Contradictor accepts that a range of approaches have been adopted by this Court to these claims as summarised by Murphy J in Ghee v BT Funds ManagementLtd [2023] FCA 1553 at [147] – [152]. The Contradictor further accepts that it is relevant to consider the number of Group Members who entered into litigation funding agreements and accepted that this item would be included as a Project Cost and that the Funder has agreed, despite its contractual entitlement, not to seek reimbursement of the deferred ATE premiums.